U.S. Venture Partners related stories
All articles and analysis
peHUB Wire: Monday, July 19, 2010Random Ramblings
- VC-Backed IPO Pipeline Springs A Leak
The VC-backed IPO pipeline was drained over the past month, with five VC-backed companies going public and two more withdrawing their offerings. Those companies represented around $1 billion in planned raise, while the month's two new registrants only plan to raise a total of $215 million. There also were two China-based issuers who both filed and priced within the month (HiSoft and AutoNavi). All of this means the current VC-backed IPO pipeline has 39 companies seeking to raise nearly $3.4 billion. That's the lowest dollar expectation since we began keeping track back in January. The full pipeline is after the jump..
- Intellikine Signs $488 Million Deal with Infinity Pharma
Intellikine Inc. has sold global development and commercialization rights to its portfolio of inhibitors of the delta and gamma isoforms of phosphoinositide-3-kinase Infinity Pharmaceuticals Inc. (Nasdaq: INFI). The deal could be worth upwards of $488.5 million, including a $13.5 million up-front payment. Intellikine has raised over $63 million in VC funding from Abingworth, CMEA Capital, Novartis Bioventures, U.S. Venture Partners, Biogen Idec, FinTech Global Capital and Sofinnova Ventures.
- peHUB Wire: Friday, July 9, 2010
Random Ramblings
- peHUB Wire: Friday, July 9, 2010
Random Ramblings
- Calithera Biosciences Raises $40 Million
Calithera Biosciences, a South San Francisco-based developer of oncology therapeutics, has raised $40 million in Series A funding. Morgenthaler Ventures led the round, and was joined by U.S. Venture Partners, Advanced Technology Ventures, Delphi Ventures and Mission Bay Capital.
- VCs weigh in what Tesla IPO means for exits
Carmaker viewed as both a cleantech startup and an expensive luxury brand
- VC-backed Solyndra withdraws IPO
Solar panel maker plans to raise $175 in notes